Is femtosecond LASIK the best option?


A comparative analysis between manual and automated surgery

Initially, flap creation was performed by means of mechanical microkeratomes, with the inconvenience of the generation of flaps that were thinner in the centre than in the periphery, (meniscus-shaped configuration).2 This meniscus of tissue behaved as an additional optical element of the ocular system, inducing new higher order aberrations and modifying the predictability of the second order correction.3

Improvements in mechanical microkeratomes aimed at providing flaps with a more homogeneous thickness profile (planar flap configuration) and of less thickness to leave a thicker stromal residual bed have been developed and introduced in the clinical setting in the last few years. Likewise, femtosecond lasers for LASIK have been also introduced, which are now considered as a significant advancement for corneal laser refractive surgery.4 This type of photodisruptive laser that uses an infrared Nd:Glass laser beam (wavelength 1053 nm) allows the surgeon to program flap creation at a predetermined depth with a high degree of precision.

Our clinical experience

The clinical histories of all patients that had undergone LASIK surgery in our centre since May 2000 were retrospectively reviewed. A total of 13000 surgical procedures had been performed with the mechanical microkeratome Hansatome (Bausch + Lomb, Rochester, New York, USA) and 2000 procedures with the Amadeus microkeratome (Ziemer Ophthalmic Systems, Port, Switzerland). A total of 800 LASIK procedures had been performed with the IntraLase iFS femtosecond technology (Abbott Medical Optics, Santa Ana, California, USA) since January 2011.

According to the clinical guidelines of our centre, a complete preoperative ophthalmological examination had been performed in all cases to evaluate the viability of the corneal surgical procedure. It included uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA), manifest refraction, slit-lamp biomicroscopy, Goldman tonometry, scotopic pupil size measurement, corneal topography, ultrasound pachymetry, biometry, ocular wavefront aberrometry and funduscopy.

The following conditions were considered as exclusion criteria for surgery: estimated stromal residual bed thickness below 250 μm after programming the laser ablation, significant corneal topographic asymmetry, cataract, glaucoma, previous ocular surgery, keratoconus, and any active ocular disease. We only considered for the analysis those cases in which the target postoperative refraction had been emmetropia.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.